4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0000899243-22-007766
Options or other derivatives
- Chief Executive Officer acquired 70,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| FRIEDMAN PAUL A Chief Executive Officer | 2022-02-22 | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | D | ||
Loading xslF345X03/doc4.xml…